West Pharmaceutical Services Operating Lease Liability Payments - 2024 (Lessee) increased by 9.8% to $20.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.4%, from $17.50M to $20.20M. Over 3 years (FY 2020 to FY 2023), Operating Lease Liability Payments - 2024 (Lessee) shows an upward trend with a 14.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher payments indicate increased short-term cash requirements for maintaining the current operational footprint.
This represents the total cash payments expected to be made for operating leases during the 2024 fiscal year. It is a fo...
Standard disclosure; peers provide this to assist in cash flow modeling and liquidity assessment.
lease_liability_payments_2024_lessee| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.40M | $9.30M | $10.70M | $11.10M | $11.60M | $14.90M | $18.10M | $16.20M | $16.70M | $17.10M | $15.70M | $16.50M | $19.80M | $20.20M | $17.50M | $18.20M | $18.40M | $20.20M |
| QoQ Change | — | -1.1% | +15.1% | +3.7% | +4.5% | +28.4% | +21.5% | -10.5% | +3.1% | +2.4% | -8.2% | +5.1% | +20.0% | +2.0% | -13.4% | +4.0% | +1.1% | +9.8% |
| YoY Change | — | — | — | — | +23.4% | +60.2% | +69.2% | +45.9% | +44.0% | +14.8% | -13.3% | +1.9% | +18.6% | +18.1% | +6.1% | -8.1% | -8.9% | +15.4% |